1. At a Glance – Jab Oxygen Business ICU Mein Ho
Hilltone Software & Gases Ltd is one of those companies where the name itself feels like a corporate split personality disorder. On one side, it sells life-saving industrial and medical gases like Oxygen, Nitrogen, Argon, and Helium. On the other, it claims to be in the “software business” without really telling anyone kaunsa software, kiske liye, aur kyun. Market cap sits at roughly ₹81 crore, current price around ₹74, and the stock has already done some cardio — up nearly 33% in 3 months and almost 90% in 6 months, which is impressive for a company reporting losses. Latest quarterly sales came in at ₹3.45 crore, up a spicy 65% YoY, but PAT said “main nahi khel raha” and slipped to a loss of ₹0.71 crore. ROCE is limping at 2.34%, ROE is negative at -1.16%, and promoter holding is a thin 12.8%, which in Indian markets is basically emotional detachment. This is a company where the top line is trying to sprint, the bottom line is crawling, and shareholders are confused whether to clap or call an ambulance.
2. Introduction – Purani Company, Nayi Kahani, Same Confusion
Incorporated back in 1993, Hilltone Software & Gases Ltd has been around long enough to remember liberalisation, dot-com bubbles, and probably dial-up internet sounds. Yet, even after three decades, it remains a microcap with single-digit revenues and recurring profitability issues. The core business is trading and supplying industrial and medical gases from its Santej plant in Gujarat, servicing hospitals and industrial clients. Fair enough. That’s a respectable, boring, steady business — or at least it should be.
Then comes the twist: software. Somewhere along the journey, Hilltone decided that gases alone were not exciting enough, so it added software integration charges to the revenue mix. In FY24, about 12% of revenue came from software, while gases contributed nearly 88%. The problem is not diversification; the problem is opacity. Investors are told there is software revenue, but not enough detail to judge scalability, margins, or moat.
Financially, the company has oscillated between small profits and losses for years. FY23 was relatively decent with ₹0.73 crore PAT, FY24 slipped to ₹0.51 crore, and FY25 ended with a loss of ₹1.26 crore. Quarterly numbers in FY26 so far suggest pressure on margins, rising expenses, and depreciation hitting harder than expected. Meanwhile, the company has been busy issuing preferential shares, increasing authorised capital, and reshuffling directors — all signs of a company in “corporate activity mode” rather than “operational excellence mode.” Investor, sawaal simple hai: business sudhar raha hai ya sirf balance sheet ghoom rahi hai?
3. Business Model – WTF Do They Even Do?
Let’s simplify Hilltone’s business like you’re explaining it to a tired CA at 11 p.m.
Core business: industrial and medical gases. Oxygen for hospitals and steel plants, Nitrogen for heat treatment and safety applications, Argon for welding and stainless steel, Hydrogen for edible oil processing, CO₂ for beverages, and Helium for specialised applications. This is mostly a trading-plus-supply model, with manufacturing and filling at Santej and delivery in cylinders and trolleys.
Clients include hospitals like SAL Hospital and Krishna Heart Institute, supplied regularly with medical oxygen cylinders. This is stable, recurring demand — hospitals don’t suddenly stop breathing because GDP growth slows.
Then there’s the software business. Officially, it contributes about 12% of revenue. Unofficially, nobody knows much about it. There’s no segment margin disclosure, no product description, and no explanation of whether it’s a scalable SaaS dream or just some integration billing to pad revenue. Think of it like adding “chef” to your Tinder bio because you once made Maggi with extra masala.
Overall, this is a low-margin, working-capital-heavy business where execution matters more than storytelling. Unfortunately, Hilltone’s numbers
